Anthony D Sung, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Campus mail Box 3961 Med Ctr, Durham, NC 27710
Phone (919) 668-1000
Email address anthony.sung@duke.edu

I am dedicated to the treatment of hematologic malignancies through cellular therapies such as hematopoietic stem cell transplantation (HCT). My research focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials. Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections. In addition to advancing new pharmacological and cellular immunotherapies in support of these goals, we also are developing mobile health technologies (mHealth) to monitor patients at home, both as part of our innovative home transplant program as well as to improve follow up care of all our patients when they return home after transplant.

In Their Words

Education and Training

  • Fellowship, Hematology Oncology, Duke University School of Medicine, 2011 - 2014
  • Residency, Osler Medical Housestaff Training Program, Johns Hopkins University School of Medicine, 2008 - 2011
  • M.D., Harvard University , 2008

Publications

Sivaraj, Dharshan, Michael M. Green, Zhiguo Li, Anthony D. Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D. Long, et al. “Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma..” Biol Blood Marrow Transplant 23, no. 2 (February 2017): 262–68. https://doi.org/10.1016/j.bbmt.2016.11.010.

PMID
27856369
Full Text

Krakow, Elizabeth F., Hui-Sheng Ai, Brian Shaffer, Jean-Sebastien Delisle, Kai-Xun Hu, and Anthony D. Sung. “Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers..” Curr Drug Targets 18, no. 3 (2017): 281–95. https://doi.org/10.2174/1389450116666150304103849.

PMID
25738297
Full Text

Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Richard Lopez, Gwynn D. Long, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning.” In Blood, 128:3395–3395. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.3395.3395.

Full Text

Sung, Anthony D., Julia A. M. Sung, Samantha Thomas, Terry Hyslop, Cristina Gasparetto, Gwynn Long, David Rizzieri, et al. “Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial..” Clin Infect Dis 63, no. 8 (October 15, 2016): 999–1006. https://doi.org/10.1093/cid/ciw451.

PMID
27481873
Full Text

Green, Michael M. B., Nelson Chao, Saurabh Chhabra, Kelly Corbet, Cristina Gasparetto, Ari Horwitz, Zhiguo Li, et al. “Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery..” J Hematol Oncol 9, no. 1 (August 17, 2016). https://doi.org/10.1186/s13045-016-0301-2.

PMID
27535663
Full Text

Anand, S., S. Thomas, T. Hyslop, K. Corbet, C. Gasparetto, G. Long, A. Morris, et al. “Transplantation of Ex vivo Expanded Umbilical Cord Blood (Nicord) Results in Decreased Infection Burden and Hospital Length of Stay in the First 100 Days.” In Bone Marrow Transplantation, 51:S52–53. NATURE PUBLISHING GROUP, 2016.

Scholars@Duke

Rizzieri, David A., Arati V. Rao, Anne Beaven, Danielle Brander, Carlos DeCastro, Louis Diehl, Thomas W. LeBlanc, et al. “Clinical and Immunomodulatiory Outcomes of Microtransplantation for AML.” In Biology of Blood and Marrow Transplantation, 22:S207–8. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.602.

Full Text

Wild, Daniel, Anthony D. Sung, Diana Cardona, Constance Cirricione, Keith Sullivan, Claire Detweiler, Michael Shealy, et al. “The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review..” Dig Dis Sci 61, no. 3 (March 2016): 806–13. https://doi.org/10.1007/s10620-015-3938-8.

PMID
26537485
Full Text

Detweiler, Claire J., Anthony D. Sung, Jennifer L. Saullo, Vinod K. Prasad, and Diana M. Cardona. “Brincidofovir (CMX001) Toxicity: Another Potential Mimicker of Gastrointestinal Graft Versus Host Disease.” In Laboratory Investigation, 96:169A-169A. NATURE PUBLISHING GROUP, 2016.

Scholars@Duke

Pages